News | October 27, 2014

Minimally Invasive Procedures Offer Hope for Elderly Patients with Heart-Valve Problems

TAVR proves effective for patients at University of Texas Southwestern Medical Center

Werner Dyer, who is now 92, had his TAVR last year and was able to rejoin his bowling league and now bowls four times a week.


October 27, 2014 – Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency. The latter turned her life into a battle for breath, eliminating almost all activities and even making sleep a struggle. She couldn’t sleep for more than 20 minutes at a time without waking in a fit of coughing. Thanks to a leading-edge procedure performed at University of Texas (UT) Southwestern Medical Center, Mrs. Henderson is now breathing – and sleeping – easy.

UT Southwestern physicians perform two types of minimally invasive valve-repair procedures that offer hope for patients like Mrs. Henderson, who have incapacitating heart-valve problems but are too frail to undergo the rigors of open-heart surgeries. 

Transcatheter aortic valve replacement (TAVR) is used to replace a critically narrowed aortic valve, the valve between the heart and the main artery in the body. TAVR patients’ narrowed aortic valves prevent sufficient blood flow. The TAVR procedure is a less invasive treatment, alleviating the narrowing without the need for open-heart surgery.

The procedure involving the MitraClip device repairs a valve between the upper and lower chambers of the left side of the heart, called the mitral valve. This valve may not close fully, causing blood to flow backward into the left atrium and lungs. The MitraClip pinches the two leafs of the mitral valve together in the center so there is less backflow of blood.

Both procedures are performed by snaking catheters, typically from a blood vessel in the groin, up to the diseased valve. Patients may experience immediate improvement, and since the only incision is a small one to allow access to the blood vessel, recovery time is short.

This summer, UT Southwestern physicians performed their 50th TAVR procedure and, recently, Sarah Gualano, M.D., assistant professor of internal medicine and medical director of the Cardiac Catheterization Laboratory, with Michael Luna, M.D., assistant professor of internal medicine, performed the first MitraClip procedures. Mrs. Henderson was one of the first MitraClip patients.   

Gualano said she has seen patients whose lives had become restricted because of their heart-valve problems re-emerging into a wider world after their procedures.

“I had a patient in his 90s who could barely walk a block, doing calisthenics in his room after his TAVR procedure. Werner Dyer, who is now 92, had his TAVR last year and was able to rejoin his bowling league and now bowls four times a week.”

“It boils down to the simple fact that these patients had no options, and now we can make them feel better and, in the case of TAVR, live longer,” said Gualano.

Demographics mean these procedures will be increasingly important in the coming years.

“We have an aging population. As people age, they become very high-risk for open-heart surgeries,” said Steven Marso, M.D., medical director of interventional cardiology and professor of internal medicine. “People who wouldn’t have had an option for treatment now have an option for treatment,” he said.

Sitting in her hospital room 36 hours after her MitraClip procedure, Mrs. Henderson was beaming. Breathing is the easy process it should be once again, and there had been no coughing the previous night. “I didn’t wake up until the nurse woke me this morning,” Mrs. Henderson said happily.

For more information: www.utsouthwestern.edu


Related Content

News | Heart Valve Technology

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid ...

Home September 04, 2024
Home
News | Heart Valve Technology

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

Home June 27, 2024
Home
News | Heart Valve Technology

June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed ...

Home June 21, 2024
Home
News | Heart Valve Technology

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial ...

Home June 10, 2024
Home
News | Heart Valve Technology

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
News | Heart Valve Technology

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
News | Heart Valve Technology

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
News | Heart Valve Technology

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
News | Heart Valve Technology

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
News | Heart Valve Technology

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...

Home December 12, 2023
Home
Subscribe Now